Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

Recent & Breaking News (TSX:VRX)

Valeant Announces Sale of iNova Pharmaceuticals for $930 Million

PR Newswire June 8, 2017

Wall Street's M&A Chatter From June 6: Valeant-Bausch & Lomb, Albany Molecular, Horizon Pharma

Benzinga.com  June 7, 2017

Safirstein Metcalf LLP and HGT Law Remind Investors About Update on Valeant Pharmaceuticals International Inc. Class Action - VRX

GlobeNewswire June 5, 2017

Watch These 8 Huge Put Purchases In Thursday Trade

Benzinga.com  June 1, 2017

Valeant Pharmaceuticals To Present At Financial Industry Conferences

PR Newswire May 31, 2017

Research Reports Coverage on Drug Delivery Stocks -- Valeant Pharma, Delcath Systems, Alkermes, and Adamis Pharma

PR Newswire May 30, 2017

Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution

PR Newswire May 22, 2017

Covered Call reports for Alibaba, Dicks Sporting Goods, Etsy Inc., Twitter and Valeant Pharmaceuticals include trade ideas that offer returns of 21% or more!

PR Newswire May 17, 2017

Statement Regarding Xifaxan Intellectual Property Litigation

PR Newswire May 17, 2017

Safirstein Metcalf LLP and HGT Law Updates Investors on Valeant Pharmaceuticals International Inc. Investor Class Action - VRX

GlobeNewswire May 15, 2017

Valeant Pharmaceuticals To Present At Health Care Conferences

PR Newswire May 10, 2017

Turing Rejects $100 Million Offer For Daraprim

Benzinga.com  May 10, 2017

20 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  May 9, 2017

The Market In 5 Minutes

Benzinga.com  May 9, 2017

25 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  May 9, 2017

Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range

PR Newswire May 9, 2017

Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025%

PR Newswire May 8, 2017

Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership

PR Newswire May 5, 2017

Watch These 5 Huge Put Purchases In Friday Trade

Benzinga.com  May 5, 2017

Watch These 8 Huge Call Purchases In Wednesday Trade

Benzinga.com  May 3, 2017